Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A43299 | 32029501 | BMJ Open | Correction: Dose-response association between physical activity and non-alcoholic fatty liver disease: a case-control study in a Chinese population. | 2020 | Details |
| A43300 | 32027859 | Lancet Gastroenterol Hepatol | Decision making for liver biopsy in NASH, not so FAST? | 2020 | Details |
| A43301 | 32026275 | Dig Dis Sci | The Emerging Epidemic of Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: True, True, and Related? | 2020 | Details |
| A43302 | 32025609 | Hepatol Commun | Tolloid-Like 1 Negatively Regulates Hepatic Differentiation of Human Induced Pluripotent Stem Cells Through Transforming Growth Factor Beta Signaling. | 2020 | Details |
| A43303 | 32025601 | Hepatol Commun | Liver Disease in Pregnancy: What's New. | 2020 | Details |
| A43304 | 32020441 | World J Pediatr | Childhood obesity, cardiovascular and liver health: a growing epidemic with age. | 2020 | Details |
| A43305 | 32016019 | Ann Transl Med | New insights into the association between non-alcoholic fatty liver disease and atherosclerosis. | 2019 | Details |
| A43306 | 32012311 | Hepatology | Is Nonalcoholic Fatty Liver Disease Not a Risk Factor for Cardiovascular Disease: Not Yet Time for a Change of Heart. | 2020 | Details |
| A43307 | 32012270 | J Cell Physiol | Effects of different fatty acids on BRL3A rat liver cell damage. | 2020 | Details |
| A43308 | 32012059 | JMIR Med Inform | Clinical Annotation Research Kit (CLARK): Computable Phenotyping Using Machine Learning. | 2020 | Details |
| A43309 | 32011391 | Eur J Gastroenterol Hepatol | Arterial and liver stiffness in patients with non-alcoholic fatty liver disease: hitting two targets with sodium-glucose co-transporter-2 inhibitors. | 2020 | Details |
| A43310 | 32011389 | Eur J Gastroenterol Hepatol | Increased prevalence of portal vein thrombosis in patients with nonalcoholic steatohepatitis-cirrhosis due to increased proinflammatory cytokines releasing from abdominal adipose tissue. | 2020 | Details |
| A43311 | 32011098 | Liver Int | Editorial: Hepatitis B virus infection and risk of nonalcoholic fatty liver disease: A population-based cohort study-authors' reply. | 2020 | Details |
| A43312 | 32007939 | J Lipid Res | Erratum: FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice. | 2020 | Details |
| A43313 | 32006524 | Transl Res | Role of placental fibrinogen-like protein 1 in gestational diabetes. | 2020 | Details |
| A43314 | 31994373 | Minerva Gastroenterol Dietol | Transaminases: oldies but goldies. A narrative review. | 2020 | Details |
| A43315 | 31992509 | Clin Res Hepatol Gastroenterol | Transient elastography for assessment of fibrosis and steatosis of liver grafts from brain-death donors. | 2020 | Details |
| A43316 | 31986920 | Expert Opin Investig Drugs | Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgery. | 2020 | Details |
| A43317 | 31985310 | Expert Opin Investig Drugs | Prof Jörn Schattenberg sheds light on key treatment and diagnostic approaches to nonalcoholic steatohepatitis (NASH). | 2020 | Details |
| A43318 | 31984804 | Expert Opin Investig Drugs | NASH and NAFLD: emerging drugs, therapeutic targets and translational and clinical challenges. | 2020 | Details |
| A43319 | 31984784 | Am J Physiol Gastrointest Liver Physiol | Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. | 2020 | Details |
| A43320 | 31981756 | Biochim Biophys Acta Mol Cell Biol Lipids | A single nucleotide polymorphism of PLIN2 is associated with nonalcoholic steatohepatitis and causes phenotypic changes in hepatocyte lipid droplets: A pilot study. | 2020 | Details |
| A43321 | 31981522 | Lancet Gastroenterol Hepatol | Addressing the global cirrhosis epidemic: one size will not fit all. | 2020 | Details |
| A43322 | 31979912 | J Assoc Physicians India | Correlation of Fibroscan with FIB-4 index and APRI for Assessment of Liver Fibrosis in patients with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43323 | 31979909 | J Assoc Physicians India | Spectrum and Clinical Profile in Patients with Non Alcolholic Fatty Liver Disease in Central India. | 2020 | Details |
| A43324 | 31979906 | J Assoc Physicians India | A Study of Non Alcoholic Fatty Liver Disease in Women with Poly Cystic Ovarian Syndrome. | 2020 | Details |
| A43325 | 31979905 | J Assoc Physicians India | APRI score: A screening marker of hepatic fibrosis in NAFLD patients. | 2020 | Details |
| A43326 | 31979903 | J Assoc Physicians India | Saroglitazar Improves Transaminases and Elastography in Patients with Diabetic Dyslipidemia and Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A43327 | 31979865 | J Assoc Physicians India | Prevalence of Non Alcoholic Fatty Pancreatic Disease (NAFPD) in General Adult Population and its Association with Type 2 Diabetes Mellitus. | 2020 | Details |
| A43328 | 31979861 | J Assoc Physicians India | Elastography Compared To APRI, FIB-4 And AST/ ALT Ratio For Assessment Of Liver Fibrosis In Non- Alcoholic Fatty Liver Disease Patients. | 2020 | Details |
| A43329 | 31979848 | J Assoc Physicians India | A Study of Non?Alcoholic Fatty Liver Disease in Type II Diabetes. | 2020 | Details |
| A43330 | 31979841 | J Assoc Physicians India | Insulin Resistance, Dyslipidaemia and Glycemic Abnormalities in Nondiabetic NAFLD (Non Alcoholic Fatty Liver Disease). | 2020 | Details |
| A43331 | 31979839 | J Assoc Physicians India | Study of Correlation between Carotid Intimalthickness and Insulin Resistance in Patients with NAFLD. | 2020 | Details |
| A43332 | 31979805 | J Assoc Physicians India | Correlative Study of HbA1c in Non Diabetic NAFLD with Carotid Intimal Medial Thickness and Abdominal Fat Indices. | 2020 | Details |
| A43333 | 31979736 | J Assoc Physicians India | Association between NAFLD and CKD and its effect on eGFR. | 2020 | Details |
| A43334 | 31979574 | J Assoc Physicians India | To Study the Occurrence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Type -II Diabetes Mellitus. | 2020 | Details |
| A43335 | 31979568 | J Assoc Physicians India | Assessment of Risk Factors for Cardiovascular Morbidity in Type 2 DM with and Without Non Alcoholic Fatty Liver Disease. | 2020 | Details |
| A43336 | 31979541 | J Assoc Physicians India | Study of Thyroid Function in Non Alcoholic Fatty Liver Disease. | 2020 | Details |
| A43337 | 31971024 | Expert Opin Investig Drugs | Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): prevalence, therapeutic innovations, and stumbling blocks for clinical development. | 2020 | Details |
| A43338 | 31970797 | Hepatology | Letter to the Editor: Regional Epidemics of Nonalcoholic Fatty Liver Disease: Timing of Westernization and Ethnicity Matter. | 2020 | Details |
| A43339 | 31959645 | Diabetes Care | Role of Exercise in Mitigating Pediatric Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43340 | 31959644 | Diabetes Care | Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes. | 2020 | Details |
| A43341 | 31953545 | J Nutr | Early Hepatic Signals of Fat Overload. | 2020 | Details |
| A43342 | 31952447 | Expert Opin Investig Drugs | Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis: opportunities and challenges. | 2020 | Details |
| A43343 | 31950816 | Acta Gastroenterol Belg | How will the welfare state cope with welfare diseases such as NASH? | 2020 | Details |
| A43344 | 31945627 | Nutr Res | A maple syrup extract alleviates liver injury in type 2 diabetic model mice. | 2019 | Details |
| A43345 | 31937400 | Clin Gastroenterol Hepatol | Daily Aspirin Use Associated With Reduced Risk for Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43346 | 31933631 | Gastroenterol Res Pract | Liver Stiffness, Not Fat Liver Content, Predicts the Length of QTc Interval in Patients with Chronic Liver Disease. | 2019 | Details |
| A43347 | 31933385 | Expert Opin Investig Drugs | Effectiveness of lifestyle interventions in NAFLD (nonalcoholic fatty liver disease) - how are clinical trials affected? | 2020 | Details |
| A43348 | 31930974 | Metabolism | Obeticholic acid for the treatment of nonalcoholic steatohepatitis: Expectations and concerns. | 2020 | Details |
| A43349 | 31930009 | Hepatobiliary Surg Nutr | Prof. Silvia Sookoian: knowledge on the natural history and the pathogenesis of non-alcoholic fatty liver disease has incremented exponentially. | 2019 | Details |
| A43350 | 31929991 | Hepatobiliary Surg Nutr | The dawn of a new era for nonalcoholic fatty liver disease? | 2019 | Details |
| A43351 | 31928993 | Lancet Gastroenterol Hepatol | Headway and hurdles in non-alcoholic fatty liver disease. | 2020 | Details |
| A43352 | 31928362 | Eur J Prev Cardiol | The 'heart' of preventive cardiology: Lifestyle medicine for the treatment of cardiometabolic diseases. | 2020 | Details |
| A43353 | 31926338 | Clin Gastroenterol Hepatol | Reply. | 2020 | Details |
| A43354 | 31925801 | Hepatology | Liver Diseases in the Perinatal Period: Interactions Between Mother and Infant. | 2020 | Details |
| A43355 | 31924553 | Clin Res Hepatol Gastroenterol | The MBOAT7 rs641738 variant in primary sclerosing cholangitis: A novel biomarker for prognostication. | 2020 | Details |
| A43356 | 31916949 | Ann Hepatol | Ruptured hepatocellular carcinoma and non-alcoholic fatty liver disease, a potentially life-threatening complication in a population at increased risk. | 2021 | Details |
| A43357 | 31911572 | Anatol J Cardiol | TAVR, NOACs, NAFLD, and a Happy New Year. | 2020 | Details |
| A43358 | 31911098 | Surg Obes Relat Dis | Response to letter to editor entitled: Improvement of nonalcoholic fatty liver disease in ALT at ≥12 months after Roux-en-Y gastric bypass and sleeve gastrectomy, no effect in ALT and AST at <12 months after SG and in AST at >12 and ≤24 months after RYGB by Wang et al. | 2019 | Details |
| A43359 | 31910158 | Endocr Connect | Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome. | 2020 | Details |
| A43360 | 31909364 | J Obes Metab Syndr | Effect of Diet on the Gut Microbiota Associated with Obesity. | 2019 | Details |
| A43361 | 31905423 | J Food Biochem | Dietary solutions to dyslipidemia: Milk protein-polysaccharide conjugates as liver biochemical enhancers. | 2020 | Details |
| A43362 | 31904864 | Hepatology | Letter to the Editor: The Association Between Diabetes and Hepatocellular Carcinoma in Patients With Cirrhosis Caused by Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43363 | 31903735 | Obesity (Silver Spring) | Adipose Tissue Macrophage Phenotypes and Characteristics: The Key to Insulin Resistance in Obesity and Metabolic Disorders. | 2020 | Details |
| A43364 | 31903616 | Hepatology | Small but Mighty: Platelets in NASH and Other Chronic Liver Diseases. | 2020 | Details |
| A43365 | 31903611 | Hepatology | Letter to the Editor: Hepatocellular Carcinoma Risk in Patients With Nonalcoholic Steatohepatitis Cirrhosis and Diabetes: Insufficient for Individual Management. | 2020 | Details |
| A43366 | 31901629 | Environ Res | Global liver proteomic analysis of Wistar rats chronically exposed to low-levels of bisphenol A and S. | 2019 | Details |
| A43367 | 31901172 | Hepatology | Reply. | 2020 | Details |
| A43368 | 31901147 | Hepatology | REPLY. | 2020 | Details |
| A43369 | 31899812 | Hepatology | Ceramides: A Cause of Insulin Resistance in Nonalcoholic Fatty Liver Disease in Both Murine Models and Humans. | 2020 | Details |
| A43370 | 31899104 | Surg Obes Relat Dis | Improvement of nonalcoholic fatty liver disease in ALT at ≥12 months after Roux-en-Y gastric bypass and sleeve gastrectomy, no effect in ALT and AST at <12 months after SG and in AST at >12 and ≤24 months after RYGB. | 2019 | Details |
| A43371 | 31893958 | Expert Opin Pharmacother | Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents. | 2020 | Details |
| A43372 | 31893256 | APL Bioeng | Emerging trends in modeling human liver disease in vitro. | 2019 | Details |
| A43373 | 31889389 | J Med Imaging Radiat Oncol | Non-alcoholic steatohepatitis mimicking solitary liver metastasis. | 2019 | Details |
| A43374 | 33777267 | Prz Gastroenterol | Exocrine pancreatic insufficiency and causes of abdominal symptoms in diabetes patients. | 2020 | Details |
| A43375 | 31887441 | Clin Gastroenterol Hepatol | Alcohol Use Patterns and Liver Outcomes: Is There Really a Difference Between Drinking Beer and Drinking Wine? | 2019 | Details |
| A43376 | 31883530 | Lipids Health Dis | A novel mutation of ABHD5 gene in a Chanarin Dorfman patient with unusual dermatological findings. | 2019 | Details |
| A43377 | 31881182 | Cell Mol Gastroenterol Hepatol | Staging NAFLD: Diagnostic and Therapeutic Value of TAM Signaling. | 2019 | Details |
| A43378 | 31876593 | AIDS | Vitamin E as a 'bridge' therapy for nonalcoholic steatohepatits in HIV: what is waiting on the other side of the bridge? | 2020 | Details |
| A43379 | 31872141 | Transl Gastroenterol Hepatol | Skeletal muscle mass and sarcopenia in nonalcoholic fatty liver disease. | 2019 | Details |
| A43380 | 31871510 | Curr Ther Res Clin Exp | Hepatoprotective Effects of a Ruthenium(II) Schiff Base Complex in Rats with Diet-Induced Prediabetes. | 2019 | Details |
| A43381 | 31868036 | Expert Opin Investig Drugs | Thyromimetics as emerging therapeutic agents for nonalcoholic steatohepatitis: rationale for the development of resmetirom (MGL-3196). | 2019 | Details |
| A43382 | 31867738 | J Food Biochem | Effect of raw and repeatedly fried mustard oil intake on metabolic and organ histological changes in Wistar rat. | 2019 | Details |
| A43383 | 31860928 | Exp Clin Endocrinol Diabetes | Diabetes and Fatty Liver. | 2019 | Details |
| A43384 | 31860245 | Am J Manag Care | NASH and liver cancer: the new cancer headline. | 2019 | Details |
| A43385 | 31859958 | Rev Med Chil | [Quality control: an essential requirement in today's practice of medicine]. | 2019 | Details |
| A43386 | 31857709 | Nat Rev Gastroenterol Hepatol | High-definition medicine: modelling NAFLD in 3D. | 2020 | Details |
| A43387 | 31852632 | Lancet Gastroenterol Hepatol | How many deaths are caused by non-alcoholic fatty liver disease in the Asia-Pacific region? | 2019 | Details |
| A43388 | 31852301 | Eur J Prev Cardiol | Non-alcoholic fatty liver disease and cardiovascular disease: A still debated liaison. | 2019 | Details |
| A43389 | 31851339 | J Nutr | Dietary Choline Supplementation Attenuates High-Fat-Diet-Induced Hepatocellular Carcinoma in Mice. | 2020 | Details |
| A43390 | 31850659 | Liver Int | Author response: Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: The Framingham study. | 2019 | Details |
| A43391 | 31850574 | Aliment Pharmacol Ther | Commentary: non-alcoholic steatohepatitis-finding and minding the fire behind the smoke. | 2020 | Details |
| A43392 | 31850557 | Aliment Pharmacol Ther | Commentary: advances in the pharmacotherapy of NASH-anti-diabetic drugs and beyond. | 2020 | Details |
| A43393 | 31850556 | Aliment Pharmacol Ther | Editorial: blood biomarkers for advanced liver fibrosis in non-alcoholic fatty liver disease-not a simple choice? | 2020 | Details |
| A43394 | 31849080 | Hepatology | Letter to the Editor: Consider More Factors When Studying Risk of Cirrhosis and Hepatocellular Cancer in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43395 | 31845444 | Phytother Res | Bitter melon fruit extract has a hypoglycemic effect and reduces hepatic lipid accumulation in ob/ob mice. | 2019 | Details |
| A43396 | 31843050 | Biomed Environ Sci | Interaction Effects of Gene Polymorphisms and Obesity on Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A43397 | 31840820 | Alcohol Clin Exp Res | RNA Sequencing Reveals a Comprehensive Circular RNA Expression Profile in a Mouse Model of Alcoholic Liver Disease. | 2020 | Details |
| A43398 | 31836462 | Chem Biol Interact | The role of cytochrome P4502E1 in the pathogenesis of alcoholic liver disease and carcinogenesis. | 2019 | Details |